ABVC BIOPHARMA, INC. — Investor Relations & Filings
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2025-10-31 | English | |
| CURRENT REPORT | 2025-10-30 | English | |
| AMENDMENT NO. 1 TO FORM 8-K | 2025-09-11 | English | |
| PROSPECTUS SUPPLEMENT | 2025-08-15 | English | |
| PROSPECTUS SUPPLEMENT | 2025-08-15 | English | |
| PROSPECTUS SUPPLEMENT | 2025-08-15 | English |
Browse filings by year
25 years- 2026 8 filings
- 2025 49 filings
- 2024 72 filings
- 2023 63 filings
- 2022 36 filings
- 2021 49 filings
- 2020 23 filings
- 2019 39 filings
- 2018 21 filings
- 2017 36 filings
- 2016 22 filings
- 2015 19 filings
- 2014 6 filings
- 2013 10 filings
- 2012 30 filings
- 2011 35 filings
- 2010 51 filings
- 2009 104 filings
- 2008 46 filings
- 2007 27 filings
- 2006 9 filings
- 2005 6 filings
- 2004 7 filings
- 2003 9 filings
- 2002 3 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 11522922 | QUARTERLY REPORT | 2025-10-31 | English | ||
| 11522936 | CURRENT REPORT | 2025-10-30 | English | ||
| 11522930 | AMENDMENT NO. 1 TO FORM 8-K | 2025-09-11 | English | ||
| 11522943 | PROSPECTUS SUPPLEMENT | 2025-08-15 | English | ||
| 11522931 | PROSPECTUS SUPPLEMENT | 2025-08-15 | English | ||
| 11522945 | PROSPECTUS SUPPLEMENT | 2025-08-15 | English | ||
| 11522942 | PROSPECTUS SUPPLEMENT | 2025-08-15 | English | ||
| 11522944 | PROSPECTUS SUPPLEMENT | 2025-08-15 | English | ||
| 11522947 | CURRENT REPORT | 2025-08-14 | English | ||
| 11522954 | Major Shareholding Notification 2025 | 2025-08-13 | English | ||
| 11522941 | QUARTERLY REPORT | 2025-08-13 | English | ||
| 11522948 | AMENDMENT NO. 1 TO FORM 8-K | 2025-07-18 | English | ||
| 11522946 | Major Shareholding Notification 2025 | 2025-07-15 | English | ||
| 11522949 | REGISTRATION STATEMENT | 2025-06-27 | English | ||
| 11522957 | CURRENT REPORT | 2025-06-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ABVC BIOPHARMA, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34380/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34380 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34380 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34380 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34380}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ABVC BIOPHARMA, INC. (id: 34380)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.